Home Your basket
• A survey of current wound...
   Price 5.50 €
• Botulinum toxin and rejuv...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Central auditory processi...
   Price 10.50 €
• Esthesioneuroblastoma in ...
   Price 8.00 €
• Lengthening temporalis my...
   Price 10.50 €
• Submental flap for auricu...
   Price 8.50 €
• Vertical extended hemi cr...
   Price 5.50 €
• Study of the supra-glotti...
   Price 10.50 €
• Recovery of saccular func...
   Price 8.50 €
• Diagnostic value of fine-...
   Price 8.50 €
• Interest of MIBI scintigr...
   Price 10.50 €
• Adenocarcinoma of the end...
   Price 8.50 €
• Anatomy of the external a...
   Price 14.00 €
• Transsexuality: Speech th...
   Price 10.50 €
• Stingy speakers....
   Price 5.50 €
• Petrosal presigmoid appro...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Advantages of combined th...
   Price 10.50 €
• Papillary thyroid microca...
   Price 8.50 €
• Mucus physiopathology, up...
   Price 12.50 €
• Central and peripherical ...
   Price 8.50 €
• Phonatory threshold press...
   Price 10.50 €
• The relevance of Choukrou...
   Price 10.50 €
• Epistaxis and hospitalisa...
   Price 10.50 €
• Osteointegrated cranio-fa...
   Price 10.50 €
• Contribution of endoscopi...
   Price 8.50 €
• A case of laryngeal sialo...
   Price 10.50 €
• The pedicle superficial t...
   Price 10.50 €
• Extramuscular soft tissue...
   Price 8.50 €
• Identification and locali...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €

Total Order 300.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2006 o

OTOLOGY

Amphicrine adenoma of the middle ear: Three cases reports and a review of the literature


Authors : K. Aubry, J. P. Sauvage, S. Puyraud (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2006;127,3:145-149.

Article published in french
Downloadable PDF document french



Summary : Amphicrine adenoma is an extremely rare tumor of the middle ear. We report three cases obtained over a twenty year period. The aim of this study is to discuss our clinical cases and review the literature. Materials and methods: Three cases of middle ear amphicrine tumour were reviewed. Results: During a 10 year period (1986-2006) three cases of middle ear amphicrine tumour were treated at our unit (2 male, 1 female). The presenting complaint was hearing loss in all 3 cases. Amphicrine adenoma is diagnosed by an immuno-histological examination of pathological specimens. Differential diagnosis can be difficult and one individual was initially treated as an adenocarcinoma by radiotherapy. This patient succumbed to cerebral mycosis two years post-radiotherapy. The other two patients have no evidence of recurrence eight and nine years post treatment. Conclusion: Historically, differential diagnosis between amphicrine adenoma and adenocarcinoma of the middle ear has been very difficult. Carcinoid tumour is considered to be a more agressive form of amphicrine adenoma. Tumour progression is through loco regional invasion. Complete excision by surgical management with long term follow up is the treatment of choice.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE